Clinical Trial - Trial ChiCTR2100050589
Access comprehensive clinical trial information for ChiCTR2100050589 through Pure Global AI's free database. This Phase 4 trial is sponsored by The Afiliated Hospital of Yunnan University and is currently Recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2100050589
Phase 4
Recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2100050589
View on Chinese Clinical Trial Registry
Untitled Trial
Phase IV clinical study evaluating the safety and immunogenicity of the third dose of inactivated SARS CoV 2 vaccine (Vero cells) in a population that did not respond to the first two doses of inactivated vaccine
Study Focus
Sponsor & Location
The Afiliated Hospital of Yunnan University
Special Project for Yunnan Social Development
China
Timeline & Enrollment
Phase 4
N/A
Aug 02, 2023
ICD-10 Classifications
COVID-19, virus identified
Viral pneumonia, unspecified
Other viral pneumonia
COVID-19, virus not identified
Pneumonia in viral diseases classified elsewhere
Data Source
Chinese Clinical Trial Registry
ChiCTR2100050589
Non-Device Trial